COMMITTED TO MAKING A DIFFERENCE
Novavax is a global biotechnology company committed to helping address serious infectious diseases globally through the discovery, development and delivery of innovative vaccines to patients around the world.
Our ESG Approach
Novavax is on a mission to protect the health of people everywhere and follow the highest standards of corporate governance. Learn more about our Environmental, Social and Governance (ESG) initiatives.
Novavax in Europe
Novavax AB
Novavax AB is located in Uppsala, Sweden. This facility is responsible for research, development and production of our saponin-based adjuvants. Our Matrix-MTM is used in multiple vaccine candidates to enhance the immune response and stimulate high levels of neutralising antibodies.
Novavax CZ
Novavax CZ, located in Bohumil in the Czech Republic, was established in 2020. The facility is a state-of-the-art vaccine and biologics manufacturing campus dedicated to producing vaccines that help protect global health.
Novavax EU
From 2022, Novavax started to develop commercial hubs throughout Europe, with the regional main office in Zurich, Switzerland. Additional offices are now also established in Brussels, Belgium and Barcelona, Spain.
How to contact Novavax
General enquiries
Media contact
Investor contact
Report an adverse effect
Report a product quality complaint
General enquiries
+44 20 3514 1838
09:00 - 17:00
Monday - Friday
Our location:
Novavax UK Limited
100 Longwater Avenue
Reading
RG2 6GP
United Kingdom
Media contact
Email: [email protected]
Phone: +41 44 553 05 71
Investor contact
To contact a member of the investor relations team, click on the "Contact us" button below.
Report an adverse effect
If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in the package leaflet.
Reporting forms and information can be found at https://yellowcard.mhra.gov.uk.
Adverse events should also be reported to Novavax on +44 203 514 1838 (09:00–17:00 Monday – Friday), or via https://uk.novavaxmedinfo.com/report-adverse-event.
When reporting, please include the vaccine brand and batch/lot number, if available.
By reporting side effects, you can help provide more information on the safety of this vaccine.
Report a product quality complaint
If you have a product quality complaint related to a physical issue with a Novavax product or its packaging, please call +44 203 514 1838 between 09:00–17:00 Monday - Friday.